KC
Kevin Caliendo UBS Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
51
Avg Return
Past Year
Past Year
0.07%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
41.2%
Neutral
58.8%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mega Cap
Over $200B
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Industrials
Healthcare
Diagnostics & Research
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
Healthcare Plans
Health Information Services
Medical Care Facilities
Medical Devices
Medical Distribution
Medical Instruments & Supplies
Pharmaceutical Retailers
Industrials
Rental & Leasing Services
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Maintained
| $325 |
14%
upside
| 2 | +4.5% |
0
%
| 17 Oct ‘25 2 days ago |
|
|
|
Neutral
Maintained
| $190 |
0%
upside
| 2 | – |
–
| 17 Oct ‘25 2 days ago |
|
|
|
Neutral
Maintained
| $155 |
19%
upside
| 1 | – |
–
| 16 Oct ‘25 3 days ago |
|
|
|
Neutral
Initiated
| $77 |
7%
upside
| 1 | – |
–
| 1 Oct ‘25 18 days ago |
|
|
|
Neutral
Maintained
| $28.25 |
1%
upside
| 2 | – |
–
| 25 Sep ‘25 24 days ago |
|
|
|
Buy
Maintained
| $860 |
9%
upside
| 1 | +6% |
0
%
| 24 Sep ‘25 25 days ago |
|
|
|
Buy
Upgraded
| $79 |
4%
downside
| 2 | +20% |
0
%
| 18 Aug ‘25 2 months ago |
|
|
|
Buy
Maintained
| $7 |
46%
upside
| 1 | -26% |
0
%
| 13 Aug ‘25 2 months ago |
|
|
|
Buy
Maintained
| $24 |
92%
upside
| 1 | -14% |
0
%
| 8 Aug ‘25 2 months ago |
|
|
|
Buy
Maintained
| $9 |
79%
upside
| 1 | +0.44% |
0
%
| 8 Aug ‘25 2 months ago |
|
|
|
Neutral
Maintained
| $70 |
11%
upside
| 1 | – |
–
| 6 Aug ‘25 2 months ago |
|
|
|
Neutral
Maintained
| $22 |
10%
upside
| 1 | – |
–
| 29 Jul ‘25 2 months ago |
|
|
|
Neutral
Maintained
| $180 |
7%
downside
| 1 | – |
–
| 25 Jul ‘25 2 months ago |
|